Password Protected Area
ILC Therapeutics is pleased to announce the launch of its final seed round of £450k prior to raising a £4m funding package to progress its COVID-19 therapeutic opportunities.
This final seed round is open to individual investors who can be classified as High Net Worth or Sophisticated Investors.
If you are interested in participating in this round please contact us for more information and to receive the Investor Pack: